{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T05:54:54Z","timestamp":1790056494821,"version":"4.0.1"},"reference-count":58,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T00:00:00Z","timestamp":1655078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007397","name":"Univerzita Karlova v Praze","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007543","name":"Grantov\u00e1 Agentura, Univerzita Karlova","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Drug-related hospital admissions (DRAs) represent a significant problem affecting all countries worldwide. This study aimed to determine the prevalence and preventability of DRAs, identify the most common medications involved in DRAs, the most common clinical manifestations of DRAs and describe the preventability aspects of DRAs.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> This cross-sectional study examined unplanned hospital admissions to the University Hospital Hradec Kr\u00e1lov\u00e9 <jats:italic>via<\/jats:italic> the department of emergency medicine in August\u2013November 2018. Data were obtained from electronic medical records. The methodology of DRA identification was adapted from the OPERAM DRA adjudication guide.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Out of 1252 hospital admissions, 195 DRAs have been identified (145 related to treatment safety, 50 related to treatment effectiveness). The prevalence of DRAs was 15.6% (95% CI 13.6\u201317.6). The most common medication classes involved in DRAs related to treatment safety were Antithrombotic agents, Antineoplastic agents, Diuretics, Corticosteroids for systemic use, and Beta blocking agents. The most common medication classes involved in DRAs related to treatment effectiveness included Diuretics, Antithrombotic agents, Drugs used in diabetes, Agents acting on the renin-angiotensin system, and Lipid modifying agents. Gastrointestinal disorders were the leading causes of DRAs related to treatment safety, while Cardiac disorders were the leading causes of DRAs related to treatment effectiveness. The potential preventability of DRAs was 51%. The highest share of potential preventability in medication classes repeatedly involved in DRAs related to treatment safety was observed for Anti-inflammatory and antirheumatic products, Psycholeptics, and Drugs used in diabetes. Potentially preventable DRAs related to treatment safety were most commonly associated with inappropriate drug selection, inappropriate monitoring, inappropriate dose selection, and inappropriate lifestyle measures. On the contrary, DRAs related to treatment effectiveness were more commonly associated with medication nonadherence.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> It should be emphasized that in most DRAs, medications were only a contributory reason of hospital admissions and that benefits and risks have to be carefully balanced. It is highlighted by the finding that the same medication classes (Antithrombotic agents and Diuretics) were among the most common medication classes involved in DRAs related to treatment safety and simultaneously in DRAs related to treatment effectiveness. The study highlighted that apart from problems related to prescribing, problems related to monitoring and patient-related problems represent significant preventability aspects.<\/jats:p>","DOI":"10.3389\/fphar.2022.899151","type":"journal-article","created":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T05:29:48Z","timestamp":1655098188000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Drug-Related Hospital Admissions via the Department of Emergency Medicine: A Cross-Sectional Study From the Czech Republic"],"prefix":"10.3389","volume":"13","author":[{"given":"Zuzana","family":"O\u010dovsk\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Ma\u0159\u00edkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarom\u00edr","family":"Ko\u010d\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji\u0159\u00ed","family":"Vl\u010dek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1111\/bcp.14577","article-title":"Cohort Study on Adverse Drug Reactions in Adults Admitted to the Medical Wards of a Tertiary Hospital in Nigeria: Prevalence, Incidence, Risk Factors and Fatality","volume":"87","author":"Adedapo","year":"2021","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s40264-016-0444-7","article-title":"Adverse-Drug-Reaction-Related Hospitalisations in Developed and Developing Countries: A Review of Prevalence and Contributing Factors","volume":"39","author":"Angamo","year":"2016","journal-title":"Drug Saf."},{"key":"B3","doi-asserted-by":"publisher","first-page":"e0186631","DOI":"10.1371\/journal.pone.0186631","article-title":"Predictors of Adverse Drug Reaction-Related Hospitalisation in Southwest Ethiopia: A Prospective Cross-Sectional Study","volume":"12","author":"Angamo","year":"2017","journal-title":"PLoS One"},{"key":"B4","doi-asserted-by":"publisher","first-page":"339","DOI":"10.29252\/beat-070401","article-title":"Drug Related Hospital Admissions; A Systematic Review of the Recent Literatures","volume":"7","author":"Ayalew","year":"2019","journal-title":"Bull. Emerg. Trauma"},{"key":"B5","first-page":"e217","article-title":"Medication-related Emergency Department Visits and Hospitalizations Among Older Adults","volume":"60","author":"Bayoumi","year":"2014","journal-title":"Can. Fam. Physician"},{"key":"B6","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1023\/a:1015570104121","article-title":"Hospitalisations Caused by Adverse Drug Reactions (ADR): a Meta-Analysis of Observational Studies","volume":"24","author":"Beijer","year":"2002","journal-title":"Pharm. World Sci."},{"key":"B7","unstructured":"MedDRA\u00ae the Medical Dictionary For Regulatory Activities Terminology (MedDRA\u00ae Trademark Is Registered by ICH) [Online]2021"},{"key":"B8","doi-asserted-by":"publisher","first-page":"n1585","DOI":"10.1136\/bmj.n1585","article-title":"Optimizing Therapy to Prevent Avoidable Hospital Admissions in Multimorbid Older Adults (OPERAM): Cluster Randomised Controlled Trial","volume":"374","author":"Blum","year":"2021","journal-title":"BMJ"},{"key":"B9","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12916-018-1104-9","article-title":"Medications that Reduce Emergency Hospital Admissions: an Overview of Systematic Reviews and Prioritisation of Treatments","volume":"16","author":"Bobrovitz","year":"2018","journal-title":"BMC Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s40264-015-0281-0","article-title":"Epidemiology of Adverse Drug Reactions in Europe: a Review of Recent Observational Studies","volume":"38","author":"Bouvy","year":"2015","journal-title":"Drug Saf."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1056\/NEJMsa1103053","article-title":"Emergency Hospitalizations for Adverse Drug Events in Older Americans","volume":"365","author":"Budnitz","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.medcli.2017.06.075","article-title":"Avoidable Hospitalizations Due to Adverse Drug Reactions in an Acute Geriatric Unit. Analysis of 3,292 Patients","volume":"150","author":"Cabr\u00e9","year":"2018","journal-title":"Med. Clin. Barc."},{"key":"B13","doi-asserted-by":"publisher","first-page":"e14768","DOI":"10.1111\/ijcp.14768","article-title":"Identifying Medication\u2010related Readmissions: Two Students Using Tools vs a Multidisciplinary Panel","volume":"75","author":"Coppes","year":"2021","journal-title":"Int. J. Clin. Pract."},{"key":"B14","first-page":"191","article-title":"Determination of Sample Size for Estimating Proportions","volume-title":"Biostatistics: A Foundation for Analysis in the Health Sciences","author":"Daniel","year":"2013"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e001161","DOI":"10.1136\/bmjoq-2020-001161","article-title":"Preventable Adverse Drug Events Causing Hospitalisation: Identifying Root Causes and Developing a Surveillance and Learning System at an Urban Community Hospital, a Cross-Sectional Observational Study","volume":"10","author":"de Lemos","year":"2021","journal-title":"BMJ Open Qual."},{"key":"B16","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1590\/s1415-790x2012000400014","article-title":"Clinical and Epidemiological Analysis of Hospitalizations of Elderly Due to Poisoning and Adverse Effects of Medications, Brazil from 2004 to 2008","volume":"15","author":"de Paula","year":"2012","journal-title":"Rev. Bras. Epidemiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1097\/pts.0000000000000627","article-title":"Hospital Admissions Associated with Medication-Related Problems in Thai Older Patients: A Multicenter Prospective Observational Study","volume":"17","author":"Dechanont","year":"2021","journal-title":"J. Patient Saf."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e054778","DOI":"10.1136\/bmjopen-2021-054778","article-title":"Prevalence and Predictors of Drug-Related Hospitalisation Among Patients Visiting Emergency Departments of Addis Ababa City Hospitals in Ethiopia: a Multicentre Prospective Observational Study","volume":"12","author":"Demessie","year":"2022","journal-title":"BMJ Open"},{"key":"B19","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00228-018-2567-5","article-title":"Defining and Classifying Terminology for Medication Harm: a Call for Consensus","volume":"75","author":"Falconer","year":"2019","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.vascn.2016.04.011","article-title":"Frequency, Types, Severity, Preventability and Costs of Adverse Drug Reactions at a Tertiary Care Hospital","volume":"81","author":"Geer","year":"2016","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"B21","doi-asserted-by":"publisher","first-page":"350","DOI":"10.3389\/fphar.2018.00350","article-title":"Adverse Drug Reactions in Hospitalized Patients: Results of the FORWARD (Facilitation of Reporting in Hospital Ward) Study","volume":"9","author":"Giardina","year":"2018","journal-title":"Front. Pharmacol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e33236","DOI":"10.1371\/journal.pone.0033236","article-title":"Percentage of Patients with Preventable Adverse Drug Reactions and Preventability of Adverse Drug Reactions-Aa Meta-Analysis","volume":"7","author":"Hakkarainen","year":"2012","journal-title":"PLoS One"},{"key":"B23","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/j.1365-2796.1990.tb00199.x","article-title":"Drug Related Hospital Admissions: the Role of Definitions and Intensity of Data Collection, and the Possibility of Prevention","volume":"228","author":"Hallas","year":"1990","journal-title":"J. Intern. Med."},{"key":"B24","unstructured":"HedmanA.\n          Uppsala, SwedenUppsala UniversityAT-HARM10 vs. OPERAM DRA Adjudication Guide - Assessment of Medication Related Hospital Admissions2020"},{"key":"B25","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/j.1365-2125.2006.02698.x","article-title":"Which Drugs Cause Preventable Admissions to Hospital? A Systematic Review","volume":"63","author":"Howard","year":"2007","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1056\/NEJMoa040135","article-title":"Rates of Hyperkalemia after Publication of the Randomized Aldactone Evaluation Study","volume":"351","author":"Juurlink","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"e323","DOI":"10.1111\/ajag.12975","article-title":"Medication\u2010related Hospital Admissions in Aged Care Residents","volume":"40","author":"Kalisch Ellett","year":"2021","journal-title":"Australas. J. Ageing"},{"key":"B28","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s11096-018-0768-8","article-title":"Assessment Tool for Hospital Admissions Related to Medications: Development and Validation in Older Patients","volume":"41","author":"Kempen","year":"2019","journal-title":"Int. J. Clin. Pharm."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e71045","DOI":"10.1371\/journal.pone.0071045","article-title":"Adverse Drug Events in Older Hospitalized Patients: Results and Reliability of a Comprehensive and Structured Identification Strategy","volume":"8","author":"Klopotowska","year":"2013","journal-title":"PLoS One"},{"key":"B30","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00228-021-03213-x","article-title":"Medication-related Adverse Events in Health Care-What Have We Learned? A Narrative Overview of the Current Knowledge","volume":"78","author":"Laatikainen","year":"2021","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1111\/bcpt.12264","article-title":"Adverse Drug Reactions Causing Hospital Admissions in Childhood: a Prospective, Observational, Single-Centre Study","volume":"115","author":"Langerov\u00e1","year":"2014","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1001\/archinternmed.2008.3","article-title":"Frequency of and Risk Factors for Preventable Medication-Related Hospital Admissions in the Netherlands","volume":"168","author":"Leendertse","year":"2008","journal-title":"Arch. Intern. Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"233","DOI":"10.2165\/11319030-000000000-00000","article-title":"The Relationship between Study Characteristics and the Prevalence of Medication-Related Hospitalizations: a Literature Review and Novel Analysis","volume":"33","author":"Leendertse","year":"2010","journal-title":"Drug Saf."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1080\/14740338.2021.1938539","article-title":"Prevalence, Characteristics, and Reporting of Adverse Drug Reactions in an Australian Hospital: a Retrospective Review of Hospital Admissions Due to Adverse Drug Reactions","volume":"20","author":"Li","year":"2021","journal-title":"Expert Opin. Drug Saf."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1007\/s11096-020-01040-1","article-title":"Medication-related Hospital Admissions and Readmissions in Older Patients: an Overview of Literature","volume":"42","author":"Linkens","year":"2020","journal-title":"Int. J. Clin. Pharm."},{"key":"B36","doi-asserted-by":"publisher","first-page":"412","DOI":"10.3389\/fphar.2020.00412","article-title":"Italian Emergency Department Visits and Hospitalizations for Outpatients' Adverse Drug Events: 12-Year Active Pharmacovigilance Surveillance (The MEREAFaPS Study)","volume":"11","author":"Lombardi","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1007\/s11096-021-01237-y","article-title":"Hospital Admissions to Geriatric Ward Related to Adverse Drug Events: a Cross-Sectional Study from the Czech Republic","volume":"43","author":"Ma\u0159\u00edkov\u00e1","year":"2021","journal-title":"Int. J. Clin. Pharm."},{"key":"B38","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.phrs.2017.07.005","article-title":"Can Causality Assessment Fulfill the New European Definition of Adverse Drug Reaction? A Review of Methods Used in Spontaneous Reporting","volume":"123","author":"Mascolo","year":"2017","journal-title":"Pharmacol. Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1136\/bmjqs-2017-007453","article-title":"Hospital Admissions Associated with Medication Non-adherence: a Systematic Review of Prospective Observational Studies","volume":"27","author":"Mongkhon","year":"2018","journal-title":"BMJ Qual. Saf."},{"key":"B40","doi-asserted-by":"publisher","first-page":"e3437","DOI":"10.1097\/MD.0000000000003437","article-title":"Adverse Drug Reactions Causing Admission to Medical Wards: A Cross-Sectional Survey at 4 Hospitals in South Africa","volume":"95","author":"Mouton","year":"2016","journal-title":"Med. Baltim."},{"key":"B41","doi-asserted-by":"publisher","first-page":"795","DOI":"10.7326\/0003-4819-140-10-200405180-00009","article-title":"Clarifying Adverse Drug Events: a Clinician's Guide to Terminology, Documentation, and Reporting","volume":"140","author":"Nebeker","year":"2004","journal-title":"Ann. Intern. Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1002\/pds.4667","article-title":"Prospective Identification versus Administrative Coding of Adverse Drug Reaction-Related Hospitalizations in the Elderly: A Comparative Analysis","volume":"27","author":"Parameswaran Nair","year":"2018","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"B43","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s00228-016-2170-6","article-title":"Hospitalizations Due to Preventable Adverse Reactions-A Systematic Review","volume":"73","author":"Patel","year":"2017","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B44","unstructured":"The PCNE Classification V 9.12020"},{"key":"B45","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1002\/pds.4184","article-title":"Burden of Hospitalizations Related to Adverse Drug Events in the USA: a Retrospective Analysis from Large Inpatient Database","volume":"26","author":"Poudel","year":"2017","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"B46","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1001\/jama.289.7.871","article-title":"Association of Serum Digoxin Concentration and Outcomes in Patients with Heart Failure","volume":"289","author":"Rathore","year":"2003","journal-title":"JAMA"},{"key":"B47","doi-asserted-by":"publisher","first-page":"951","DOI":"10.2165\/11316750-000000000-00000","article-title":"Medication-related Admissions in Older People: a Cross-Sectional, Observational Study","volume":"26","author":"Rogers","year":"2009","journal-title":"Drugs Aging"},{"key":"B48","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1080\/14740338.2018.1415322","article-title":"Preventable ADRs Leading to Hospitalization - Results of a Long-Term Prospective Safety Study with 6,427 ADR Cases Focusing on Elderly Patients","volume":"17","author":"Schmiedl","year":"2018","journal-title":"Expert Opin. Drug Saf."},{"key":"B49","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s12603-009-0237-0","article-title":"Contribution of Drug Related Problems to Hospital Admission in the Elderly","volume":"14","author":"Somers","year":"2010","journal-title":"J. Nutr. Health Aging"},{"key":"B50","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1111\/bcp.13716","article-title":"Development of a Standardized Chart Review Method to Identify Drug-Related Hospital Admissions in Older People","volume":"84","author":"Thevelin","year":"2018","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"567424","DOI":"10.3389\/fphar.2021.567424","article-title":"Medication-Related Hospital Readmissions within 30 Days of Discharge: Prevalence, Preventability, Type of Medication Errors and Risk Factors","volume":"12","author":"Uitvlugt","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1345\/aph.1D182","article-title":"Drug-related Problem Classification Systems","volume":"38","author":"van Mil","year":"2004","journal-title":"Ann. Pharmacother."},{"key":"B53","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies","volume":"82","author":"von Elm","year":"2008","journal-title":"Rev. Esp. Salud Publica"},{"key":"B54","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1111\/bcp.15012","article-title":"Methodological Issues in Research on Drug\u2010related Admissions: A Meta\u2010epidemiological Review with Focus on Causality Assessments","volume":"88","author":"Wallerstedt","year":"2021","journal-title":"Brit J. Clin. Pharma"},{"key":"B55","first-page":"11","article-title":"Pharmaceutical Care and the Role of Drug-Related Problems","volume-title":"The Pharmacist Guide to Implementing Pharmaceutical Care","author":"Westerlund","year":"2019"},{"key":"B56","unstructured":"The Anatomical Therapeutic Chemical Classification System [Online]2022"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1345\/aph.1A225","article-title":"Preventable Drug-Related Hospital Admissions","volume":"36","author":"Winterstein","year":"2002","journal-title":"Ann. Pharmacother."},{"key":"B58","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/imj.14134","article-title":"Trends in Adverse Drug Reaction-Related Hospitalisations over 13 Years in New South Wales, Australia","volume":"49","author":"Zhang","year":"2019","journal-title":"Intern. Med. J."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.899151\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T10:50:11Z","timestamp":1656586211000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.899151\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,13]]},"references-count":58,"alternative-id":["10.3389\/fphar.2022.899151"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.899151","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,13]]},"article-number":"899151"}}